May 1, 2024 - Quote of the Day
“The most terrifying words in the English language are: I'm from the government and I'm here to help.” – Said Former US President Ronald Reagan
This author has not written his bio yet.
But we are proud to say that april@madhedgefundtrader.com contributed 2301 entries already.
“The most terrifying words in the English language are: I'm from the government and I'm here to help.” – Said Former US President Ronald Reagan
When John identifies a strategic exit point, he will send you an alert with specific trade information as to what security to sell, when to sell it, and at what price. Most often, it will be to TAKE PROFITS, but, on rare occasions, it will be to exercise a STOP LOSS at a predetermined price to adhere to strict risk management discipline.
( THE YEN IS FACING A DILEMMA) May 1, 2024 Hello everyone, Welcome to May, and what could be a continuation of the market behaviour we saw in April. The market is in the doldrums about what the Fed might say on Wednesday. Investors are already interpreting and theorizing possible outcomes, hence
Global Market Comments May 1, 2024 Fiat Lux Featured Trade: (SEVEN REASONS TO BUY CHARLES SCHWAB), (SCHW), (TLT), (GS), (MS), (C), (BAC), (TESTIMONIAL), (TAKING A BITE OUT OF STEALTH INFLATION)
Looking for a financial to add to your tech-heavy portfolio? I think the nimble investor can pick up shares of online broker Charles Schwab (SCHW) and gain an outsized return. That’s assuming that the current correction in the stock market remains in single digits, and doesn’t explode into a full-blown bear market. There are many
Dear John, I loved your trades this year! 10% plus in a day? I’ll take as many of those as you can dream up. And pulling this off in this boring market is incredible. After reading BS and extreme negativity in my other newsletters all day long, you are a breath of fresh air. Keep
When I visited the local fire station in the spring, I was snared by some uniformed pre-teens, backed by beaming mothers behind a card table selling Girl Scout cookies. I was a pushover. I walked away with a bag of Thin Mints, Lemon Chalet Creams, Do-Si-Dos, and Tagalongs. I have to confess a lifetime addiction
When John identifies a strategic exit point, he will send you an alert with specific trade information as to what security to sell, when to sell it, and at what price. Most often, it will be to TAKE PROFITS, but, on rare occasions, it will be to exercise a STOP LOSS at a predetermined price to adhere to strict risk management discipline.
Mad Hedge Biotech and Healthcare Letter April 30, 2024 Fiat Lux Featured Trade: (HITTING CTRL+ALT+DELETE ON DRUG R&D) (DNA), (GOOGL), (JNJ), (ILMN), (JNJ), (ALTO), (GROIV)
Forget your classic biotech launch story. One of 2024's most lavishly funded biotech upstarts is taking a massively ambitious swing at reinventing the entire drug development process. I'm talking AI, venture billions, and some serious star power all rolled into one wild capital extravaganza. The company behind this cash-flushed disruption bid is Xaira Therapeutics. And
Legal Disclaimer
There is a very high degree of risk involved in trading. Past results are not indicative of future returns. MadHedgeFundTrader.com and all individuals affiliated with this site assume no responsibilities for your trading and investment results. The indicators, strategies, columns, articles and all other features are for educational purposes only and should not be construed as investment advice. Information for futures trading observations are obtained from sources believed to be reliable, but we do not warrant its completeness or accuracy, or warrant any results from the use of the information. Your use of the trading observations is entirely at your own risk and it is your sole responsibility to evaluate the accuracy, completeness and usefulness of the information. You must assess the risk of any trade with your broker and make your own independent decisions regarding any securities mentioned herein. Affiliates of MadHedgeFundTrader.com may have a position or effect transactions in the securities described herein (or options thereon) and/or otherwise employ trading strategies that may be consistent or inconsistent with the provided strategies.